stata v 12 1 software (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
stata v 12 1 software
Stata V 12 1 Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+12+1/STATA+12%2E0/pm41194102-73-6-6
Average 99 stars, based on 36686 article reviews
Stata V 12 1 Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v+12+1/STATA+12%2E0/pm41194102-73-6-6
Average 99 stars, based on 36686 article reviews
stata v 12 1 software - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
other:Article Title: Relationship between Tai Chi and clinical outcomes in elderly patients with COVID-19: a protocol for systematic review and dose-response meta-analysis. Article Snippet: Two independent reviewers will select the studies, extract the data, and analyse them on EndNote V.X9.0 and Article Title: Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease Article Snippet: Statistical analyses were performed using GraphPad Prism V.9.4.0 and Article Title: Raising the bar on fibrinogen: a retrospective assessment of critical hypofibrinogenemia in severely injured trauma patients Article Snippet: Statistical analysis was performed with Article Title: Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease. Article Snippet: Statistical analyses were performed using GraphPad Prism V.9.4.0 and Article Title: Relationship between Tai Chi and clinical outcomes in elderly patients with COVID-19: a protocol for systematic review and dose-response meta-analysis. Article Snippet: Article Title: Prevalence and impact of chronic dysglycaemia among patients with COVID-19 in Swedish intensive care units: a multicentre, retrospective cohort study Article Snippet: We analysed data using Article Title: Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK. Article Snippet: We performed sensitivity analyses where we restricted analyses to individuals with eGFR values recorded in the year before the start of follow- up, and stratified results by CKD status at the start date, and by whether the start date was before or after the publication of the EMPAREG- OUTCOME Study in 2015.15 As differential mortality could influence the results, we performed further sensitivity analyses using Fine and Gray models to calculate adjusted subdistribution HRs (SHRs) where death was considered a competing risk for the CV/renal outcomes.16 Finally, we also performed an alternative analysis using inverse probability of treatment weighting using propensity scores to adjust for potential confounders.17 Analyses were undertaken using Article Title: Prevalence and impact of chronic dysglycaemia among patients with COVID-19 in Swedish intensive care units: a multicentre, retrospective cohort study. Article Snippet: We analysed data using |